Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
atezolizumab (Tecentriq) (1 trial)
dsp107 (2 trials)
kahr-102 (1 trial)
azacitidine (vidaza) (1 trial)
venetoclax (venclexta) (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Lymphoma (Phase 2)
Trials (3 total)
Trial APIs (5 total)